Category: Urological Cancers

Alpha-fetoprotein (AFP) is a protein normally produced by the developing fetus during pregnancy. Its presence in adult circulation typically signals something unusual, prompting investigation into…

Bladder cancer is often diagnosed at an early stage, making it highly treatable. Radiation therapy stands as a crucial component in many treatment plans, particularly…

Prostate cancer is one of the most commonly diagnosed cancers in men worldwide. While advancements in treatment have significantly improved outcomes, managing recurrence and accurately…

Renal cell carcinoma (RCC) is often diagnosed at an early stage, frequently through incidental imaging findings. This has led to improved survival rates over recent…

The discovery of a small mass within the testicle can understandably cause significant anxiety. It’s crucial to remember that finding such a mass doesn’t automatically…

Bladder cancer, while often detected early through routine examinations or changes in urinary habits, can sometimes present with atypical symptoms, including the development of a…

Non-seminomatous germ cell tumors (NSGCTs) represent the most common type of testicular cancer, accounting for roughly 90-95% of all testicular malignancies. These tumors arise from…

PSA Relapse After Prostatectomy: Understanding Recurrence Prostate cancer is one of the most common cancers affecting men, and for many, treatment involves radical prostatectomy –…

Posterior bladder wall tumors represent a significant clinical challenge in urological oncology. Their location – nestled at the back of the bladder – often complicates…

Clear cell carcinoma is the most common subtype of kidney cancer, accounting for approximately 85-90% of all renal malignancies. It originates in the proximal convoluted…